ArticleRadiology. Artificial intelligence2024
Improving Computer-aided Detection for Digital Breast Tomosynthesis by Incorporating Temporal Change.
Article in Radiology. Artificial intelligence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin Lymphoma.International journal of radiation oncology, biology, physics · 2026Article
- Integrating Clinical Workflow for Breast Cancer Screening with AI.Radiology. Artificial intelligence · 2024Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
Abstract
Purpose To develop a deep learning algorithm that uses temporal information to improve the performance of a previously published framework of cancer lesion detection for digital breast tomosynthesis. Materials and Methods This retrospective study analyzed the current and the 1-year-prior Hologic digital breast tomosynthesis screening examinations from eight different institutions between 2016 and 2020. The dataset contained 973 cancer and 7123 noncancer cases. The front end of this algorithm was an existing deep learning framework that performed single-view lesion detection followed by ipsilateral view matching. For this study, PriorNet was implemented as a cascaded deep learning module that used the additional growth information to refine the final probability of malignancy. Data from seven of the eight sites were used for training and validation, while the eighth site was reserved for external testing. Model performance was evaluated using localization receiver operating characteristic curves. Results On the validation set, PriorNet showed an area under the receiver operating characteristic curve (AUC) of 0.931 (95% CI: 0.930, 0.931), which outperformed both baseline models using single-view detection (AUC, 0.892 [95% CI: 0.891, 0.892];
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.